CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 14 of 14 entries

View as:

Point of Service Diabetes Screening Evaluation

Phase: N/A Priority: Normal

NCT ID: NCT01669616 Org: User:

Start: 08/31/12 End: 01/31/13 Due: 01/31/14

Evaluation of SCOUT DS in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT01346033 Org: User:

Start: 10/31/10 End: 10/31/10 Due: 10/31/11

Evaluation and Comparison of Noninvasive Blood Glucose Concentrations

Phase: N/A Priority: Normal

NCT ID: NCT01745900 Org: User:

Start: 12/31/12 End: 03/31/13 Due: 03/31/14

Customer Support Response Study

Phase: N/A Priority: Normal

NCT ID: NCT01547403 Org: User:

Start: 08/31/12 End: 01/31/13 Due: 01/31/14

Evaluation of a Noninvasive Diabetes Screening Device in Subjects at Risk for Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT01080157 Org: User:

Start: 03/31/10 End: 12/31/10 Due: 12/31/11

Bias Source of Signal in SCOUT DS

Phase: N/A Priority: Normal

NCT ID: NCT01550328 Org: User:

Start: 04/30/12 End: 01/31/13 Due: 01/31/14

Evaluation of Low Source of Signal in SCOUT DS

Phase: N/A Priority: Normal

NCT ID: NCT01339637 Org: User:

Start: 04/30/11 End: 10/31/11 Due: 10/31/12

A Study Comparing Skin Fluorescence to Coronary Artery Calcification

Phase: N/A Priority: Normal

NCT ID: NCT00895427 Org: User:

Start: 02/28/09 End: 09/30/11 Due: 09/30/12

Evaluation of SCOUT DS Device in the Diagnosis of Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT01634997 Org: User:

Start: 06/30/12 End: - Due: -

Screening for Early Evidence of Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00614783 Org: User:

Start: 05/31/07 End: 12/31/10 Due: 12/31/11

Evaluation of SCOUT DS in Subjects With Type 2 Diabetes #2

Phase: N/A Priority: Normal

NCT ID: NCT01346046 Org: User:

Start: 05/31/11 End: 08/31/11 Due: 08/31/12

Evaluation of SCOUT DS Device in the Diagnosis of Diabetes Mellitus

Phase: N/A Priority: Normal

NCT ID: NCT01572415 Org: User:

Start: 09/30/11 End: 03/31/12 Due: 03/31/13

Noninvasive Screening for Early Evidence of Diabetes With SCOUT DS

Phase: N/A Priority: Normal

NCT ID: NCT01375686 Org: User:

Start: 06/30/11 End: 10/31/11 Due: 10/31/12

Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications

Phase: N/A Priority: Normal

NCT ID: NCT01415115 Org: User:

Start: 03/31/07 End: 08/31/11 Due: 08/31/12

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Point of Service Diabetes Screening Evaluation	NCT01669616	VeraLight, Inc.	user2@example.com	None	2012-08-31	2013-01-31	2014-01-31	-	-	2025-07-14
Evaluation of SCOUT DS in Subjects With Type 2 Diabetes	NCT01346033	VeraLight, Inc.	user2@example.com	None	2010-10-31	2010-10-31	2011-10-31	-	-	2025-07-14
Evaluation and Comparison of Noninvasive Blood Glucose Concentrations	NCT01745900	VeraLight, Inc.	user2@example.com	None	2012-12-31	2013-03-31	2014-03-31	-	-	2025-07-14
Customer Support Response Study	NCT01547403	VeraLight, Inc.	user2@example.com	None	2012-08-31	2013-01-31	2014-01-31	-	-	2025-07-14
Evaluation of a Noninvasive Diabetes Screening Device in Subjects at Risk for Diabetes	NCT01080157	VeraLight, Inc.	user2@example.com	None	2010-03-31	2010-12-31	2011-12-31	-	-	2025-07-14
Bias Source of Signal in SCOUT DS	NCT01550328	VeraLight, Inc.	user2@example.com	None	2012-04-30	2013-01-31	2014-01-31	-	-	2025-07-14
Evaluation of Low Source of Signal in SCOUT DS	NCT01339637	VeraLight, Inc.	user2@example.com	None	2011-04-30	2011-10-31	2012-10-31	-	-	2025-07-14
A Study Comparing Skin Fluorescence to Coronary Artery Calcification	NCT00895427	VeraLight, Inc.	user2@example.com	None	2009-02-28	2011-09-30	2012-09-30	-	-	2025-07-14
Evaluation of SCOUT DS Device in the Diagnosis of Diabetes	NCT01634997	VeraLight, Inc.	user2@example.com	None	2012-06-30	-	-	-	-	2025-07-14
Screening for Early Evidence of Diabetes	NCT00614783	VeraLight, Inc.	user2@example.com	None	2007-05-31	2010-12-31	2011-12-31	-	-	2025-07-14
Evaluation of SCOUT DS in Subjects With Type 2 Diabetes #2	NCT01346046	VeraLight, Inc.	user2@example.com	None	2011-05-31	2011-08-31	2012-08-31	-	-	2025-07-14
Evaluation of SCOUT DS Device in the Diagnosis of Diabetes Mellitus	NCT01572415	VeraLight, Inc.	user2@example.com	None	2011-09-30	2012-03-31	2013-03-31	-	-	2025-07-14
Noninvasive Screening for Early Evidence of Diabetes With SCOUT DS	NCT01375686	VeraLight, Inc.	user2@example.com	None	2011-06-30	2011-10-31	2012-10-31	-	-	2025-07-14
Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications	NCT01415115	VeraLight, Inc.	user2@example.com	None	2007-03-31	2011-08-31	2012-08-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance